Stockhub

Samjin Pharmaceuticals Co., Ltd.: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

22 September 2022

  • curprev 08:4108:41, 22 September 2022‎ 95.149.241.133 talk‎ 857 bytes +857‎ Created page with "== Summary<ref>Source: Yahoo Finance.</ref> == Samjin Pharmaceuticals Co., Ltd. engages in the research and development of pharmaceutical products in Korea. The company's products include SA001, a clinical Phase II product for the treatment of dry eye and sjogren syndrome; SJP1803/1804, a preclinical stage product for the treatment of macular degeneration; SJP601 and SJP1602 preclinical stage products for the treatment of cancer; SPJ1604 and SPJ003 clinical phase produc..." Tag: Visual edit: Switched
Retrieved from ‘https://stockhub.co/research/Samjin_Pharmaceuticals_Co.,_Ltd.’